Evira

Continuous care. Human connection.

Better obesity care. Beyond the appointment.

Help your team turn everyday progress into timely, individualised support — and build a stronger care relationship with patients and families.

Developed in Sweden.Working with NHS specialist services.

Who we work with

NHS specialist obesity services across England.

See all customer cases →
Alder Hey Children's NHS Foundation Trust logoBirmingham Women's and Children's NHS Foundation Trust logoUniversity Hospitals Bristol and Weston NHS Foundation Trust logoCambridge University Hospitals NHS Foundation Trust logoUniversity Hospitals of Leicester NHS Trust logoNottingham University Hospitals NHS Trust logoManchester University NHS Foundation Trust logoLancashire Teaching Hospitals NHS Foundation Trust logoNewcastle upon Tyne Hospitals NHS Foundation Trust logoUniversity Hospitals Plymouth NHS Trust logoUniversity Hospital Southampton NHS Foundation Trust logoAshford and St Peter's Hospitals NHS Foundation Trust logoFrimley Health NHS Foundation Trust logoDartford and Gravesham NHS Trust logoEast Suffolk and North Essex NHS Foundation Trust logo

Clinical effect

Twice as effective as conventional treatment

Evira strengthens the alliance with families through regular feedback and support. In a Swedish pragmatic trial, the larger reduction in BMI Z-score after one year was maintained at three years.

Evira digi-physical treatment, 107 children
Conventional standard treatment, 321 children

Average BMI Z-score over three years for the digi-physical treatment group and matched standard-treatment group, adjusted for sex, age and degree of obesity at treatment start. This Swedish study is not an NHS service outcome.

Read the peer-reviewed three-year study →

Evira in the NHS

Digital support across specialist NHS obesity pathways

Evira is used alongside different models of specialist CEW care — from regional hubs and local spokes to home-first and hybrid pathways.

Explore public evidence, implementation experience and service outcomes from NHS teams across England.

11

NHS CEW services featured

8 + 3

Hubs + spokes

6

NHS England regions

Cases span published Evira evaluations, service outcomes, pathway redesign and real-world implementation.

The Evira approach

Obesity doesn't pause between appointments.
Care shouldn't either.

A meaningful change in a patient's progress can happen long before their next visit. Evira connects home monitoring with clinical judgement, helping your team respond when support is needed.

01

Measure at home

A numberless scale and app help patients and families follow progress against an individual treatment goal.

Patient & family
02

Understand the trend

Your care team reviews progress between visits, alongside the patient's circumstances and clinical needs.

Clinical team
03

Respond with care

Use personal feedback to recognise progress, work through difficulties and agree the next step together.

A shared conversation
Context matters

Alongside appointments, with review frequency and clinical responsibility agreed by your service. Evira supports treatment delivered by your team; it is not a separate care provider.

In the CEW clinic

What UK teams say it changes

Specialist teams describe the difference as knowing sooner — and being able to act while it still matters.

UK · CEW clinical practice
“Having access to live progress allows us to intervene in real time, reaching out to reflect on progress and overcome challenges.”Jayne, CEW Clinical Nurse Specialist, UK
Capacity

More contact, same team

Follow-up happens across the caseload rather than appointment by appointment, so families can be seen more often within existing staffing.
Governance

Procurement-ready

DTAC evidence pack, DCB0129 clinical risk management, DSP Toolkit and DPIA support for your assessment team.
7,000+
Paediatric patients
6,000+
Adult users
2x
Better outcomes
7
Countries
60+
Centres
The challenge

Short-term programmes aren't solving a long-term problem

Obesity is a chronic condition — yet most services still deliver short, clinic-bound 12-week programmes. They are resource-heavy, hard to sustain and end up driving repeat demand. In England, 66% of adults and 26% of children aged 2–15 are overweight or living with obesity.

Evira takes a different route: continuous digital support running alongside clinical care, so teams can deliver long-term follow-up without scaling staff in proportion. Sustained behavioural change instead of episodic care.

£6.5bn
NHS obesity costs / year
£58bn
Annual cost in the UK
14m
People living with obesity

NHS Digital 2024 · Health Survey for England, Jan 2026

Digiphysical care

We combine digital and physical care

Evira bridges the gap between clinic visits with daily remote monitoring, family messaging and proactive intervention — so teams can deliver high-quality care even when distances are great.

Daily remote monitoring

A connected scale at home — no numbers shown. Daily measurements flow straight to the clinical dashboard.

In-app messaging

Families reach their care team whenever they need to. AI-powered translation supports multilingual populations.

MDT clinical dashboard

The full treatment history is available to the multidisciplinary team. Search, filter and sort. 2–4 minutes per patient per week.

AI growth estimation

Individualised height-growth predictions yield real-time, accurate BMI SDS values for children and young people.

10+ languages, traffic-light design

Simple visual indicators for varying health literacy plus AI translation in messaging — accessible to diverse populations.

Whole-family approach

Several household members can use the same device with separate secure accounts — supporting family-wide collaboration.

Evira with GLP-1 medication

The behavioural companion for GLP-1 treatment

Around 10% of children in UK CEW services using Evira are now also receiving GLP-1 medication. Evira provides the behavioural monitoring, dosing communication and lifestyle support that make pharmacotherapy more effective.

Learn about Evira & GLP-1 →
Procurement-ready

Information governance & compliance

DTAC, DSPT, Cyber Essentials, DCB0129, CE marked, ICO registered. We provide complete evidence packs to accelerate your procurement.

DTAC compliant

Digital Technology Assessment Criteria.

DCB0129 & DCB0160

Clinical risk management standards.

DSP Toolkit

Data Security & Protection Toolkit.

CE marked

Medical device, class I.

Cyber Essentials

Certified for Cyber Essentials.

ICO registered

UK GDPR compliant.

We can provide a complete DTAC evidence pack, help you complete DPIA templates, and supply data processing agreements. View full compliance documentation →

Trusted by the evidence

Clinically validated in published, peer-reviewed research with Karolinska Institutet

-0.30
BMI SDS reduction / year

Roughly twice the effect of traditional treatment when using Evira.

3 yrs
Sustained outcomes

Treatment effects maintained at three-year follow-up. KI 2025.

78%
Family satisfaction

Compared with 11% in traditional care — particularly strong in adolescents.

Sustainability

Supporting NHS net zero ambitions

By shifting care from clinic-based to digital-first delivery, Evira reduces environmental impact across the pathway.

Reduced patient travel

Home-based monitoring and digital follow-up replace many in-person visits — fewer journeys for patients and staff.

Device reuse

The numberless scale is durable, reusable, and refurbishable when returned. Several household members share one device.

Less clinic resource use

Less reliance on printed materials. Digital communication replaces letters and paper forms.

Hybrid workforce support

Clinicians can review dashboards and reply to messages remotely, reducing staff travel where appropriate.

Ready to transform your service?

A scalable solution for long-term weight management — built to support ICB and Trust priorities in prevention, inequalities, sustainability and cost efficiency.

Book a demonstration